HPV Ups Cervical Cancer Risk, Even With No Cellular Signs
HPV-16/18 confers strong future risk, particularly in women younger than 30 years
FDA Approves Drugs for Treatment of Two Rare Blood Diseases
Elzonris approved to treat BPDCN; Ultomiris approved for paroxysmal nocturnal hemoglobinuria
CDC: Weight, Waist Size, BMI Increased for Many U.S. Adults
1999-2000 to 2015-2016 saw increase in mean weight, waist circumference, BMI for many subgroups
FDA Warns Companies on Unsafe, Unapproved Stem Cell Treatments
Patients contracting deadly infections at clinics offering the unapproved treatments
Pembrolizumab Promising for Metastatic Head, Neck SCC
Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma
Sorafenib for Desmoid Tumors Ups Progression-Free Survival
Two-year progression-free survival rate 81 percent with sorafenib vs. 36 percent with placebo
Growth in Use of Telemedicine Seen From 2005 to 2017
Significantly faster increase in use of telemental health services seen in counties with no psychiatrists
Affordable Care Act Sign-Ups Higher Than Expected
As of last Saturday's enrollment deadline, 8.5 million people in 39 states had enrolled
Endocrine Tx Does Not Impair Neuropsychological Performance
Findings observed in early-stage breast cancer survivors followed for up to six years after treatment
Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer
Disease-free, overall survival significantly longer compared with gemcitabine, but more adverse events
